RIG-I and TLR-7/8 agonists as combination adjuvant shapes unique antibody and cellular vaccine responses to seasonal influenza vaccine.
第一作者:
Sonia,Jangra
第一单位:
Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.;Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
作者:
医学主题词
动物(Animals);人类(Humans);小鼠(Mice);佐剂, 免疫(Adjuvants, Immunologic);抗体, 病毒(Antibodies, Viral);免疫球蛋白G(Immunoglobulin G);流感疫苗(Influenza Vaccines);流感, 人(Influenza, Human);白细胞介素4(Interleukin-4);Toll样受体7(Toll-Like Receptor 7);Toll样受体8(Toll-Like Receptor 8)
DOI
10.3389/fimmu.2022.974016
PMID
36426358
发布时间
2024-06-27
- 浏览0
Frontiers in immunology
974016页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



